Hypertension (high blood pressure) Board decisions

The Board granted service connection for left lower extremity radiculopathy and remanded several other claims, including those for a mental health condition, left shoulder disability, costochondritis, reactive airway disease, and hypertension. The claim for lumbosacral strain to include herniated disc was dismissed.

The Board denied the Veteran's claims for increased ratings and remanded several service connection claims due to insufficient evidence.

The Board granted service connection for bilateral hearing loss and tinnitus, but denied service connection for vertigo, depression, anxiety, headaches, a neck disability, dermatitis, erectile dysfunction, hypertension, sleep apnea, chronic fatigue, and a back disability.

The Veteran's appeal for service connection for various conditions was dismissed due to a late filing of the Board Appeal request.

The Board granted a 30 percent rating for migraines and service connection for tinnitus, while denying increased ratings for bilateral hearing loss, chronic rhinitis, pyelonephritis with UTI, and all other conditions on appeal.

The Board remands the claims for service connection for hypertension, bilateral restless leg syndrome, and a vein condition to correct duty to assist errors.

The Board granted service connection for hypertension as secondary to the Veteran's service-connected disabilities.

The Board granted service connection for hypertension and denied an initial rating in excess of 50 percent for major depressive disorder, while remanding claims for service connection for diabetes mellitus, a headache disability (secondary to major depressive disorder, hypertension or diabetes), and a disability manifested by urinary frequency as secondary to hypertension or diabetes.

The Board denied service connection for obstructive sleep apnea and hypertension, as well as initial ratings in excess of 10 percent for a scar under the right eye, an initial compensable rating for disfigurement due to a scar under the right eye, and an initial compensable rating for a left upper back scar.

The Veteran was granted a 100 percent rating for his heart disability from January 24, 2023, and special monthly compensation (SMC) under the provisions of 38 U.S.C. § 1114(s) beginning February 15, 2024; however, an initial compensable rating for hypertension was denied.

The Board dismissed the appeals for service connection of chronic fatigue, hypertension, cardiovascular ailments, fibromyalgia, erectile dysfunction, OSA, migraines, lower back pain, and Gulf War Syndrome due to untimely filings or lack of clarification.

The Board denied increased ratings for the veteran's service-connected conditions and granted SMC at the statutory housebound rate from July 5, 2023. The decision also remanded several claims related to secondary service connection.

The Board granted a 10 percent rating for GERD from October 15, 2024, and denied a compensable rating for hypertension. Sleep apnea was granted service connection.

The Board remands the claims for service connection for various conditions, including PTSD and other psychiatric disorders, hypertension, and musculoskeletal issues, to ensure compliance with duty to assist requirements.

The veteran's appeal requests for service connection and increased ratings were dismissed as they were not timely filed.

The Board granted readjudication of the claim for entitlement to service connection for hypertension due to new and relevant evidence being received.

The Veteran's service-connected disabilities, specifically PTSD and migraines, rendered him unemployable as of February 1, 2023.

The Board denied the veteran's claims for an earlier effective date for service connection for hypertension and end stage renal disease with renal transplant, as there was no evidentiary or legal basis to support an earlier effective date.

The appeal for service connection for hypertension and high cholesterol was dismissed due to a defect in the July 2025 VA Form 10182, as these issues had already been appealed and adjudicated by the May 2025 Board decision.

The Board remands the claims for service connection for prostate cancer, hypertension, and diabetes mellitus type II due to duty-to-assist errors and a need for additional development of evidence related to in-service chemical exposures.